Your browser doesn't support javascript.
loading
[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program.
Barry, Nathaniel; Koh, Eng-Siew; Ebert, Martin A; Moore, Alisha; Francis, Roslyn J; Rowshanfarzad, Pejman; Hassan, Ghulam Mubashar; Ng, Sweet P; Back, Michael; Chua, Benjamin; Pinkham, Mark B; Pullar, Andrew; Phillips, Claire; Sia, Joseph; Gorayski, Peter; Le, Hien; Gill, Suki; Croker, Jeremy; Bucknell, Nicholas; Bettington, Catherine; Syed, Farhan; Jung, Kylie; Chang, Joe; Bece, Andrej; Clark, Catherine; Wada, Mori; Cook, Olivia; Whitehead, Angela; Rossi, Alana; Grose, Andrew; Scott, Andrew M.
Afiliação
  • Barry N; School of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
  • Koh ES; Centre for Advanced Technologies in Cancer Research (CATCR), Perth, WA, Australia.
  • Ebert MA; South Western Sydney Clinical School, University of New South Wales, Australia.
  • Moore A; School of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
  • Francis RJ; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
  • Rowshanfarzad P; Australian Centre for Quantitative Imaging, Medical School, University of Western Australia, Crawley, WA, Australia.
  • Hassan GM; Centre for Advanced Technologies in Cancer Research (CATCR), Perth, WA, Australia.
  • Ng SP; Trans Tasman Radiation Oncology Group (TROG) Cancer Research, Newcastle, NSW Australia.
  • Back M; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
  • Chua B; Australian Centre for Quantitative Imaging, Medical School, University of Western Australia, Crawley, WA, Australia.
  • Pinkham MB; School of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
  • Pullar A; Centre for Advanced Technologies in Cancer Research (CATCR), Perth, WA, Australia.
  • Phillips C; School of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
  • Sia J; Department of Radiation Oncology, Austin Health, Heidelberg, VIC, Australia.
  • Gorayski P; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Le H; Department of Radiation Oncology, Royal Brisbane Womens Hospital, Brisbane, QLD, Australia.
  • Gill S; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Croker J; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Bucknell N; Department of Radiation Oncology, Peter MacCallum Cancer Centre, VIC, Australia.
  • Bettington C; Department of Radiation Oncology, Peter MacCallum Cancer Centre, VIC, Australia.
  • Syed F; Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Jung K; Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Chang J; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
  • Bece A; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
  • Clark C; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
  • Wada M; Department of Radiation Oncology, Royal Brisbane Womens Hospital, Brisbane, QLD, Australia.
  • Cook O; Department of Radiation Oncology, The Canberra Hospital, Canberra, ACT, Australia.
  • Whitehead A; Department of Radiation Oncology, The Canberra Hospital, Canberra, ACT, Australia.
  • Rossi A; South Western Sydney Clinical School, University of New South Wales, Australia.
  • Grose A; Department of Radiation Oncology, St George Hospital, Kogarah, NSW, Australia.
  • Scott AM; Department of Radiation Oncology, St George Hospital, Kogarah, NSW, Australia.
Phys Imaging Radiat Oncol ; 30: 100568, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38585372
ABSTRACT
Background and

purpose:

The [18]F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing program aimed to assess the feasibility in Radiation Oncologist (RO) derivation of standard-of-care target volumes (TVMR) and hybrid target volumes (TVMR+FET) incorporating pre-defined FET PET biological tumour volumes (BTVs). Materials and

methods:

Central review and analysis of TVMR and TVMR+FET was undertaken across three benchmarking cases. BTVs were pre-defined by a sole nuclear medicine expert. Intraclass correlation coefficient (ICC) confidence intervals (CIs) evaluated volume agreement. RO contour spatial and boundary agreement were evaluated (Dice similarity coefficient [DSC], Jaccard index [JAC], overlap volume [OV], Hausdorff distance [HD] and mean absolute surface distance [MASD]). Dose plan generation (one case per site) was assessed.

Results:

Data from 19 ROs across 10 trial sites (54 initial submissions, 8 resubmissions requested, 4 conditional passes) was assessed with an initial pass rate of 77.8 %; all resubmissions passed. TVMR+FET were significantly larger than TVMR (p < 0.001) for all cases. RO gross tumour volume (GTV) agreement was moderate-to-excellent for GTVMR (ICC = 0.910; 95 % CI, 0.708-0.997) and good-to-excellent for GTVMR+FET (ICC = 0.965; 95 % CI, 0.871-0.999). GTVMR+FET showed greater spatial overlap and boundary agreement compared to GTVMR. For the clinical target volume (CTV), CTVMR+FET showed lower average boundary agreement versus CTVMR (MASD 1.73 mm vs. 1.61 mm, p = 0.042). All sites passed the planning exercise.

Conclusions:

The credentialing program demonstrated feasibility in successful credentialing of 19 ROs across 10 sites, increasing national expertise in TVMR+FET delineation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Phys Imaging Radiat Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Phys Imaging Radiat Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália